Why the study?
What are the prognostic factors for survival in patients with malignant fibrous histiocytoma?
What are the prognostic factors for survival in patients with malignant fibrous histiocytoma?
Answers are grounded in this paper and cite their sources.
Tumor grade, size, and distant metastases at presentation are the most important prognostic factors for malignant fibrous histiocytoma.
BACKGROUND: A thorough understanding of malignant fibrous histiocytoma (MFH), the most common subtype of soft tissue sarcoma, will lead to improved histologic-specific protocols. METHODS: 126 patients with histologically confirmed MFH were analyzed. The median follow-up was 42 months (range 1-233 months). RESULTS: Overall survival was 58% at 5 years and 38% at 10 years. Grade significantly influenced prognosis, with 10-year survival of 90%, 60%, and 20% for low, intermediate, and high grade tumors, respectively (p = 0.0007). Distant metastases at initial presentation (p = 0.0002) and size of the primary tumor (p = 0.0007) influenced outcome. Neither anatomic site nor depth of the primary tumor were significant prognostic factors. Positive microscopic margins were associated with a decreased disease-free survival (p = 0.006). CONCLUSIONS: Tumor grade, size, and distant metastases at initial presentation remain the most important prognostic factors for MFH. Resection with negative microscopic margins decreased the incidence of local recurrence.
No takes yet. Share an insight, caveat, or question.
Gibbs et al. (2001) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: